Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-24 @ 1:03 PM
NCT ID:
NCT01968161
Eligibility Criteria:
Inclusion Criteria:
* Meeting DSM-IV criteria for schizophrenia (SZ) or related SZ spectrum psychotic disorders
* having provided a consent to include data on our databank,and being able to provide informed consent
* willingness to participate to the assessments
* being over 18 years of age
* being in a clinical situation that warrants switch to asenapine
Exclusion Criteria:
* suffering from a primary drug-induced psychosis
* being at significant risk for suicide or assault
* unstable medical condition
* persistence of psychotic symptoms despite adequate treatment to an extent that clozapine would be required
* being treated with antipsychotic for 5 years or more
* having contraindications(allergy to asenapine)
* being pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01968161
Study Brief:
Protocol Section:
NCT01968161